1.MAFbx and MuRF1 mRNA expression and its relationship with muscular contractility following free muscle transfer.
An-Tang LIU ; Da-Zhi YU ; Ying-Fan ZHANG ; Wen-Jun ZHANG ; Wei-Jin DING ; An-Jing REN ; Chao-Ping FANG ; Hua JIANG
Chinese Journal of Plastic Surgery 2009;25(3):217-221
OBJECTIVETo study muscle atrophy F-box (MAFbx) and muscle ring finger 1 (MuRF1) mRNA expression and its relationship with muscular contraction following free muscle transfer.
METHODSThe gracilis muscle was orthotopic transferred in adult rat to establish the animal model. The muscle at the unoperated side was used as control. The expression of MAFbx and MuRF1 mRNA, the muscle contraction and muscle function were measured by real-time PCR and multiple function physiological device. The relationship among the expression of MAFbx and MuRF1 mRNA, the muscle contraction and muscle function was analyzed.
RESULTSAfter muscle free transfer, muscle wet weight reservation, the maximum contraction and tetanus strength reduce first and increased later, but still lower than those at control side. The expression of MAFbx and MuRF1 mRNA reached peak level 3 - 4 weeks after muscle transfer which was 7.1 and 4.1 times as that at control side. It decreased later, but still higher than that at control side, showing a significant difference between them (P< 0. 05).
CONCLUSIONSPersistent over-expression of MAFbx and MuRF1 mRNA after muscle transfer has a close relationship with muscle atrophy and muscle dysfunction. MAFbx and MuRF1 can be used as markers for early muscle atrophy, and also as potential target for drug treatment of muscle atrophy.
Animals ; Female ; Muscle Contraction ; Muscle Proteins ; genetics ; Muscle, Skeletal ; pathology ; Muscular Atrophy ; genetics ; metabolism ; pathology ; RING Finger Domains ; RNA, Messenger ; genetics ; Rats ; Rats, Sprague-Dawley ; SKP Cullin F-Box Protein Ligases ; genetics ; Tripartite Motif Proteins ; Ubiquitin-Protein Ligases ; genetics
2.Experimental study on protective effect of small interfering RNA-induced Atrogin-1 gene silencing on muscle cell malnutrition.
Lei YUAN ; Guo-Hao WU ; Bo ZHANG
Chinese Journal of Surgery 2009;47(9):705-708
OBJECTIVETo investigate the protective effect of Atrogin-1 gene silencing via RNA interference technique on a model of muscle cell malnutrition.
METHODSSequences of five target Atrogin-1 siRNA and the control were selected and synthesized and cloned to vector pBS-hU6-I and then to vector FG12. The length and rightness of the sequences were confirmed. The recombinant FG12 vectors were cotransfected along with pRSVREV, pMDLg/pRRE and pHCMV-G into 293T cells to package lentivirus particles, with which C2C12 cells were infected. The infected C2C12 cells were cultured and differentiated to form myotubes before TNF-alpha was added to induce malnutrition. Expressed products of Atrogin-1 of myotubes were identified by real time PCR and Western blot methods. Myotubes were observed and photographed directly in culture plate without fixation.
RESULTSThe length and sequences of inserted DNA were right. Compared with the RNA interferencing group, significant atrophy and upregulated expression of Atrogin-1 of myotubes treated by TNF-alpha was found in the control group.
CONCLUSIONAtrogin-1 gene silencing could be used to inhibit malnutrition of muscle cells caused by TNF-alpha. Atrogin-1 could be an ideal target in the treatment of cancer cachexia.
Animals ; Cell Differentiation ; Cell Proliferation ; Cells, Cultured ; Gene Silencing ; Genetic Vectors ; Lentivirus ; genetics ; Mice ; Muscle Cells ; cytology ; drug effects ; metabolism ; Muscle Proteins ; genetics ; RNA, Small Interfering ; genetics ; SKP Cullin F-Box Protein Ligases ; genetics ; Transfection ; Tumor Necrosis Factor-alpha ; pharmacology
3.Interaction of SerpinB5 and MAFbx in gastric cancer cell and its action site.
Ke-feng LEI ; Yi-fei WANG ; Qun-qun WANG ; Xiang-hong HE ; Bing-ya LIU ; Xue-hua CHEN ; Bei-qin YU ; Zheng-gang ZHU
Chinese Journal of Gastrointestinal Surgery 2012;15(2):169-173
OBJECTIVETo explore the interaction between SerpinB5 and MAFbx in gastric cancer cell and to identify the interaction sites.
METHODSThe interaction between SerpinB5 and MAFbx was screened and validated by yeast two-hybrid screening and co-immunoprecipitation. The expression of MAFbx was analyzed after SerpinB5 expression being modified by RNA interference and pGBKT7-SerpinB5 transfection. The impact of SerpinB5 on the expression of MAFbx was studied in gastric cancer cell line SUN-16. A model of MAFbx was constructed by homology modeling. The related residues for interaction were analyzed by Autodock4.0.
RESULTSThe interaction between SerpinB5 and MAFbx was validated. The expression of MAFbx changed along with SerpinB5 expression. Amino acids including PRO261, ASN361, and LYS362 were key residue in the interaction of SerpinB5 and MAFbx.
CONCLUSIONSerpinB5 interacts with MAFbx in gastric cancer cell. Amino acids including PRO261, ASN361, and LYS362 are potential binding sites.
Cell Line, Tumor ; Humans ; Immunoprecipitation ; Muscle Proteins ; genetics ; metabolism ; RNA Interference ; SKP Cullin F-Box Protein Ligases ; genetics ; metabolism ; Serpins ; genetics ; metabolism ; Stomach Neoplasms ; genetics ; metabolism ; Two-Hybrid System Techniques
4.Therapeutic effect of massage on denervated skeletal muscle atrophy in rats and its mechanism.
Xiao-Feng WAN ; Cheng-Lin TANG ; Dan-Dan ZHAO ; Hui-Yu AN ; Xiang MA ; Tong-Xi QIAO
Chinese Journal of Applied Physiology 2019;35(3):223-227
OBJECTIVE:
To investigate the therapeutic effects of massage on denervated skeletal muscle atrophy in rats and its mechanism.
METHODS:
Forty-eight male SD rats were randomly divided into model group (n=24) and massage group (n=24). Gastrocnemius muscle atrophy model was established by transecting the right tibial nerve of rat. On the second day after operation, the gastrocnemius muscle of the rats in the massage group was given manual intervention and the model group was not intervened. Six rats were sacrificed at the four time points of 0 d, 7 d, 14 d and 21 d. The gastrocnemius of the rats were obtained and measured the wet mass ratio after weighing. Cross-sectional area and diameter of the muscle fiber were measured after HE staining. The relative expressions of miR-23a, Akt, MuRF1 and MAFbx mRNA were tested with qPCR.
RESULTS:
Compared with 0 d, the wet weight ratio, cross-sectional area and diameter of gastrocnemius muscle showed a progressive decline in the model group and massage group. The wet weight ratio, cross-sectional area and diameter of gastrocnemius muscle in the massage group were higher than those in the model group on 7 d, 14 d and 21 d (P<0.05, P<0.01). Compared with 0 d, the expressions of MuRF1, MAFbx and Akt mRNA were increased first and then were decreased in the model group and massage group. The expression of MuRF1 mRNA in massage group was lower than that in model group on 7 d and 21 d (P<0.05, P<0.01). The expression of MAFbx mRNA in massage group was lower than that in model group on 7 d, 14 d and 21 d (P<0.01, P<0.05, P<0.01). The expression of Akt mRNA in massage group was higher than that in model group on 7 d, 14 d and 21 d (P<0.05, P<0.01). Compared with 0 d, the expression of miR-23a mRNA was increased in the model group and massage group on 21 d, and the expression of miR-23a mRNA in massage group was higher than that in model group (P< 0.05).
CONCLUSION
Massage can delay the atrophy of denervated skeletal muscle. The mechanism may be related to up-regulation of the expression of miR-23a and Akt mRNA, down-regulation of the expressions of MuRF1 and MAFbx mRNA, inhibition of protein degradation rate, and reduction of skeletal muscle protein degradation.
Animals
;
Male
;
Massage
;
MicroRNAs
;
metabolism
;
Muscle Fibers, Skeletal
;
Muscle Proteins
;
metabolism
;
Muscle, Skeletal
;
physiopathology
;
Muscular Atrophy
;
therapy
;
Proto-Oncogene Proteins c-akt
;
metabolism
;
Rats
;
Rats, Sprague-Dawley
;
SKP Cullin F-Box Protein Ligases
;
metabolism
;
Tripartite Motif Proteins
;
metabolism
;
Ubiquitin-Protein Ligases
;
metabolism
5.Research update of Cullin protein in reproductive system.
Ye TIAN ; Han ZHAO ; Zi-jiang CHEN
Acta Academiae Medicinae Sinicae 2013;35(1):125-129
Culling protein is a member of Cullin-Ring-based E3-ligases ( CRLs family) , which belong to E3 ubiquitin ligases. Cullin plays diverse and essential roles in many biological processes through mediating the ubiquitination of target proteins. This article summarizes the potential functions of Culling proteins in gamete genesis and maturation, embryo development, and reproductive related disorders.
Cullin Proteins
;
Humans
;
Urogenital System
7.Molecular Mechanism of CRBN in the Activity of Lenalidomid eagainst Myeloma--Review.
Wen-Jing FAN ; Zhi-Qiao FAN ; Mei-Juan YANG ; Yao-Zhu PAN ; Hai BAI
Journal of Experimental Hematology 2018;26(4):1240-1243
Cereblon(CRBN) is a brain-associated protein with ionic protease activity, which interacts with DNA damage-binding protein-1 (DDB1), Cullin 4 (Cul4A or Cul4B), and regulator of Cullins 1 (RoC1) to form the functional E3 ubiquitin ligase complex(CRBN-CRL4) that performs proteolysis via the ubiquitin-proteasome pathway. And CRBN is a necessary target protein for the anti-myeloma effect of immunomodulators. The combination of lenalidomide and CRBN recruited a new substrate that binds to the CRBN-CRL4 complex, leading to increased ubiquitination and proteasome-dependent degradation, thus resulting in anti-myeloma activity. The substrates binding to this complex are IKZF1, IKZF3 proteins and GS, etc. The CRBN-dependent degradation of IKZF1 and IKZF3 after lenalidomide treatment is also the result of HO-mediated oxidative stress. In addition to ubiquitination, lenalidomide also mediates ubiquitin-independent pathways that prevent CRBN from binding to CD147-MCT1 in a competitive manner to regulate its antitumor activity. Lenalidomide can also play a role in multiple myeloma(MM) cells by modulating miRNA levels and CRBN binding to downstream protein AGO2 expression. Thus, there are many molecular mechanisms of lenalidomide anti-myeloma activity. This review summarizes the molecular mechanisms of CRBN in lenalidomide against myeloma activity in terms of ubiquitin-dependent and ubiquitin-independent pathways.
Cullin Proteins
;
Humans
;
Hydrogen Peroxide
;
Multiple Myeloma
;
Peptide Hydrolases
;
Proteolysis
;
Thalidomide
;
Ubiquitination
8.DDB1- and CUL4-associated factor 8 plays a critical role in spermatogenesis.
Xiuli ZHANG ; Zhizhou XIA ; Xingyu LV ; Donghe LI ; Mingzhu LIU ; Ruihong ZHANG ; Tong JI ; Ping LIU ; Ruibao REN
Frontiers of Medicine 2021;15(2):302-312
Cullin-RING E3 ubiquitin ligase (CRL)-4 is a member of the large CRL family in eukaryotes. It plays important roles in a wide range of cellular processes, organismal development, and physiological and pathological conditions. DDB1- and CUL4-associated factor 8 (DCAF8) is a WD40 repeat-containing protein, which serves as a substrate receptor for CRL4. The physiological role of DCAF8 is unknown. In this study, we constructed Dcaf8 knockout mice. Homozygous mice were viable with no noticeable abnormalities. However, the fertility of Dcaf8-deficient male mice was markedly impaired, consistent with the high expression of DCAF8 in adult mouse testis. Sperm movement characteristics, including progressive motility, path velocity, progressive velocity, and track speed, were significantly lower in Dcaf8 knockout mice than in wild-type (WT) mice. However, the total motility was similar between WT and Dcaf8 knockout sperm. More than 40% of spermatids in Dcaf8 knockout mice showed pronounced morphological abnormalities with typical bent head malformation. The acrosome and nucleus of Dcaf8 knockout sperm looked similar to those of WT sperm. In vitro tests showed that the fertilization rate of Dcaf8 knockout mice was significantly reduced. The results demonstrated that DCAF8 plays a critical role in spermatogenesis, and DCAF8 is a key component of CRL4 function in the reproductive system.
Animals
;
Cullin Proteins/genetics*
;
DNA-Binding Proteins/genetics*
;
Factor VIII
;
Male
;
Mice
;
Mice, Knockout
;
Spermatogenesis/genetics*
;
Ubiquitin-Protein Ligases
9.Identification and characterization of cul-3b, a novel hominine CUL-3 transcript variant.
Li LU ; Zuo-Ming ZHOU ; Xiao-Yan HUANG ; Min XU ; Lan-Lan YIN ; Hui WANG ; Zhi-Yang XU ; Jia-Hao SHA
Asian Journal of Andrology 2005;7(2):205-211
AIMTo identify genes related to the human testis development by substrate hybridization technique.
METHODSA human testis cDNA microarray was constructed and hybridized with probes prepared from human adult and fetal testes and spermatozoa mRNAs by reverse transcription reactions. The differentially expressed genes were sequenced. And a newly identified cullin-3 (CUL-3) transcript variant (designated cul-3b) was bio-informatically analyzed with an online GenBank database. Multi-tissue reverse transcription polymerase chain reaction (RT-PCR) was used to determine the tissue expression profile of cul-3b.
RESULTSCul-3b, a novel CUL-3 transcript variant, was identified. The expression level of cul-3b in adult testes was 3.79-fold higher than that in fetal ones. Cul-3b differed from cul-3 (including NM_003590 and AY337761) in the opening reading frame and had three internal ribosomal entry sites IRESes in the 5'-UTR. These led to a 24 amino acid (aa) truncation at N-terminus of CUL-3b as compared with CUL-3 and a more motivated expression pattern of cul-3b under some strict circumstances. Additionally, cul-3b expressed ubiquitously in human tissues according to multi-tissue RT-PCR.
CONCLUSIONCul-3b is a novel transcript variant of CUL-3, which may be important not only for the development of human testis but also for that of other organs.
Base Sequence ; Cell Cycle Proteins ; genetics ; Cullin Proteins ; genetics ; Humans ; Molecular Sequence Data ; RNA, Messenger ; genetics ; Reverse Transcriptase Polymerase Chain Reaction
10.The CUL4A ubiquitin ligase is a potential therapeutic target in skin cancer and other malignancies.
Chinese Journal of Cancer 2013;32(9):478-482
Cullin 4A (CUL4A) is an E3 ubiquitin ligase that directly affects DNA repair and cell cycle progression by targeting substrates including damage-specific DNA-binding protein 2 (DDB2), xeroderma pigmentosum complementation group C (XPC), chromatin licensing and DNA replication factor 1 (Cdt1), and p21. Recent work from our laboratory has shown that Cul4a-deficient mice have greatly reduced rates of ultraviolet-induced skin carcinomas. On a cellular level, Cul4a-deficient cells have great capacity for DNA repair and demonstrate a slow rate of proliferation due primarily to increased expression of DDB2 and p21, respectively. This suggests that CUL4A promotes tumorigenesis (as well as accumulation of skin damage and subsequent premature aging) by limiting DNA repair activity and expediting S phase entry. In addition, CUL4A has been found to be up-regulated via gene amplification or overexpression in breast cancers, hepatocellular carcinomas, squamous cell carcinomas, adrenocortical carcinomas, childhood medulloblastomas, and malignant pleural mesotheliomas. Because of its oncogenic activity in skin cancer and up-regulation in other malignancies, CUL4A has arisen as a potential candidate for targeted therapeutic approaches. In this review, we outline the established functions of CUL4A and discuss the E3 ligase's emergence as a potential driver of tumorigenesis.
Animals
;
Carcinogenesis
;
metabolism
;
Cell Cycle
;
Cell Proliferation
;
Cullin Proteins
;
genetics
;
metabolism
;
DNA Damage
;
DNA Repair
;
DNA-Binding Proteins
;
metabolism
;
Drug Delivery Systems
;
Humans
;
Neoplasms
;
genetics
;
metabolism
;
Proto-Oncogene Proteins p21(ras)
;
metabolism
;
Skin Neoplasms
;
genetics
;
metabolism
;
pathology